Page last updated: 2024-11-03

risperidone and Agenesis of Hemidiaphragm

risperidone has been researched along with Agenesis of Hemidiaphragm in 1 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
"This short report provides guidance for antipsychotic medication dosing to improve early intervention outcomes."1.56Early behavioral and developmental interventions in ADNP-syndrome: A case report of SWI/SNF-related neurodevelopmental syndrome. ( Hopkin, R; Pedapati, E; Shillington, A; Suhrie, K, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Shillington, A1
Pedapati, E1
Hopkin, R1
Suhrie, K1

Other Studies

1 other study available for risperidone and Agenesis of Hemidiaphragm

ArticleYear
Early behavioral and developmental interventions in ADNP-syndrome: A case report of SWI/SNF-related neurodevelopmental syndrome.
    Molecular genetics & genomic medicine, 2020, Volume: 8, Issue:6

    Topics: Antipsychotic Agents; Autism Spectrum Disorder; Behavioral Symptoms; Child, Preschool; Early Medical

2020